Home
>
National Drug Code (NDC)
>
KYPROLIS
KYPROLIS - 76075-101-01 - (carfilzomib)
Drug Information of KYPROLIS
| Product NDC: | 76075-101 |
| Proprietary Name: | KYPROLIS |
| Non Proprietary Name: | carfilzomib |
| Active Ingredient(s): | 60 mg/30mL & nbsp; carfilzomib |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of KYPROLIS
| Product NDC: | 76075-101 |
| Labeler Name: | Onyx Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA202714 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20120720 |
Package Information of KYPROLIS
| Package NDC: | 76075-101-01 |
| Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (76075-101-01) > 30 mL in 1 VIAL, SINGLE-USE |
NDC Information of KYPROLIS
| NDC Code | 76075-101-01 |
| Proprietary Name | KYPROLIS |
| Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (76075-101-01) > 30 mL in 1 VIAL, SINGLE-USE |
| Product NDC | 76075-101 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | carfilzomib |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20120720 |
| Marketing Category Name | NDA |
| Labeler Name | Onyx Pharmaceuticals, Inc. |
| Substance Name | CARFILZOMIB |
| Strength Number | 60 |
| Strength Unit | mg/30mL |
| Pharmaceutical Classes | Proteasome Inhibitor [EPC],Proteasome Inhibitors [MoA] |
